Assistant or Associate Professor of Pharmaceutical Sciences (AI Focus)

Screen reader users may encounter difficulty with this site. For assistance with applying, please contact . If you have questions while submitting an application, please review these frequently asked questions.

Current Employees and Students:

If you are currently employed or enrolled as a student at The Ohio State University, please log in to to use the internal application process.

Job Title:
Assistant or Associate Professor of Pharmaceutical Sciences (AI Focus)

The Division of Pharmaceutics and Pharmacology in the College of Pharmacy at The Ohio State University invites applications at the Assistant or Associate Professor level for a tenure-track or tenured faculty position in Pharmaceutical Sciences. With a research emphasis on contemporary approaches for discovery, development, or optimization of drug therapies and/or models of disease and drug resistance, competitive applicants will have established or developing research programs that integrate artificial intelligence and other emerging computational approaches to address fundamental and translational challenges in the pharmaceutical sciences.

Ohio State’s university-wide AI(X) Hub is a multidisciplinary initiative that brings together researchers across 15 colleges to advance artificial intelligence for the public good. AI(X) Hub is expanding Ohio State University’s research community through recruitment of 100 AI-focused faculty members and is organized around six strategic pillars, including AI for Health. Through this initiative and the broader collaborative environment at Ohio State, the successful candidate will have opportunities to work with AI researchers, other pharmaceutical scientists, basic and translational biomedical investigators, clinicians, and industry partners across Ohio State.

Research areas of interest include, but are not limited to:

• Innovative integration of artificial intelligence (AI) and machine learning (AI/ML) in pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulation

• Quantitative systems pharmacology (QSP) and physiologically based pharmacokinetic (PBPK) modeling

• Mining and analysis of published and real-world datasets for disease modeling, biomarker discovery, patient stratification, and predictive modeling of efficacy and toxicity

• Development of digital twins and simulation-based models to forecast drug behavior across biological scales—from subcellular to population levels—including early ADME predictions, image-based drug response modeling, and immunomodulation of tumor microenvironments

• Enhancing translational research efficiency and applying computational models to clinical trial design and disease-specific contexts

• AI-driven integration of genomic data to enable highly personalized treatment strategies tailored to individual genetic and disease profiles
• Collaborative research with experts in drug discovery, targeted delivery, disease biology, data science, and clinical pharmacology

Collaborative Environment

The successful candidate will join a highly collaborative environment within the Division of Pharmaceutics and Pharmaceutical Sciences and the broader College of Pharmacy.

The position is expected to contribute to the AI(X) Hub’s AI for Health mission by developing innovative, responsible, and translational AI approaches that accelerate therapeutic discovery and improve human health. The university’s AI for Health initiative is designed to connect advances in AI with biomedical research, clinical needs, and real-world health applications.

Performance Objectives

• Develop or continue an independent and focused program of research and scholarship that has national and international recognition
• Establish or maintain a record of competitive grant and/or contract funding, including from federal funding sources, that supports a productive research program
• Achieve excellence in teaching and mentoring, including the training and mentoring of graduate students
• Demonstrate service and leadership within the college and university and participate in service in professional activities
  

Education and Experience Requirements

• A Ph.D., Pharm.D., or equivalent doctoral degree in pharmaceutical sciences, pharmacology, biochemistry, biophysics, computer science, or a closely related field.
• A strong record of fundamental or applied research at the intersection of artificial intelligence and development or optimization of drug therapy, demonstrated through impactful publications, promise or success in securing extramural funding, and professional recognition.
• Demonstrated creativity and originality, with the potential to establish new concepts, methodologies, frameworks, or applications in AI-enabled drug development, personalized therapy, or optimization of existing drug theraies.
• Evidence of the potential to develop an independent, collaborative, and externally funded research program.
• A commitment to excellence in teaching, mentorship, and service.

Ohio State provides access to a depth and breadth of opportunities and resources. Starting your first day, Ohio State offers you a comprehensive benefits package.

How to Apply

You will be presented with the opportunity to attach up to FIVE documents in the Application Documents section. Please include the following:

• Attachment 1: Cover Letter: 1-2 pages that should include a summary of your academic background and why you are interested in this opportunity.
• Attachment 2: CV (Curriculum Vitae): Detailed overview of your scholarly experience, including your research experience, teaching and mentoring experience, service, funding, and publications.
• Attachment 3: Research Statement: Summary of your past research accomplishments, current work/research, and proposal for your future research plan as a faculty member.
• Attachment 4: Teaching Statement: A statement of your approaches, experience and philosophy regarding your teaching, learning, and mentoring.
• Attachment 5: References: Names and contact information of three individuals who could be contacted for letters of reference.
  

Application closes 12/31/2026

The College

Established in 1885, The Ohio State University College of Pharmacy is a global leader in pharmaceutical education, research and clinical practice. As part of one of the most comprehensive health sciences campuses in the nation, the college is home to world-class faculty, dedicated researchers and top-notch students who are leading the way in patient care outcomes, drug discovery and translational pharmacology. The college has received nearly $60 million in research awards over the past five years. Additionally, we are the only school of pharmacy in the nation to have twice received the American Association of Colleges of Pharmacy (AACP) 2023 Lawrence C. Weaver Transformative Community Service Award for our dedication to addressing unmet needs through education, practice and research. We are consistently ranked as a top ten school in the nation and are currently ranked fourth by U.S. News and World Report. Learn more at pharmacy.osu.edu.

Division Information

The mission of the faculty, scientists, students and staff of the Division of Pharmaceutics and Pharmacology is the discovery and development of drug therapies for the treatment of human disease. The training of the next generation of pharmaceutical scientists at the undergraduate (BS), professional (PharmD), graduate (PhD), and postdoctoral levels is intertwined with this mission. The Division of Pharmaceutics and Pharmacology researchers are leaders in the use of state-of-the-art technologies to conduct research centered around five major themes: 

Cancer Therapeutics: The discovery of anti-cancer drug targets, identification/circumvention of drug resistance mechanisms, optimization of drug delivery and disposition, and development of novel therapies are major areas of focus for the division. Our anti-cancer therapeutics research leverages our expertise in novel drug delivery systems, drug transport and membrane trafficking, basic/translational/clinical pharmacology, pharmacogenomics and pharmacometrics to improve outcomes for cancer patients.

Cell Protective Therapies: Preclinical studies of mechanisms of cell death and strategies to enhance cell survival are under active investigation in the division. This knowledge will contribute to the development of therapies to reduce inflammatory and degenerative processes in patients with neurologic, cardiovascular and renal diseases.

Drug Delivery Systems: There is a need for improved delivery strategies of toxic therapeutics, newly developed biologics, and cell and gene therapies to the target site(s) in the body and prevent interactions with healthy tissues. Our research spans expertise in pharmaceutical chemistry, bioengineering, and RNA nanotechnology to develop future on-target medicines to improve human disease treatment.

Drug Toxicity: Understanding the mechanisms underlying the unwanted and adverse effects of drug therapies is a major area of investigation in the division. Knowledge of how drugs enter normal cells and exert toxic effects will help the design of strategies to mitigate this damage and improve patient health. Drug-drug interactions (DDIs) also contribute to adverse drug reactions in patients. Identification of mechanisms underlying DDIs is another area of investigation. Drug transporter and pharmacology principles are integral to this research theme.

Bacterial Infectious Diseases: A key research area, integrating pharmacokinetics, pharmacodynamics, and microbiology to optimize antimicrobial therapy. This work focuses on understanding interactions among pathogens, antibiotics, and the host to improve outcomes and limit resistance. Central to this effort is leveraging PK/PD relationships to define exposure–response dynamics and guide rational dosing that maximizes efficacy while minimizing toxicity and resistance emergence. Collaborative research targets the identification of novel antimicrobial strategies, improved drug design, and combination therapies for multidrug-resistant organisms. Using translational approaches spanning in vitro, in vivo, and clinical models, this work bridges mechanistic insight with patient outcomes to advance precision antimicrobial therapy and address the growing burden of resistant infections.

Located in Ohio’s capital city, Ohio State’s Columbus campus is near